ArticleBMJ (Clinical research ed.)2020
Managing long covid: don't overlook olfactory dysfunction.
Article in BMJ (Clinical research ed.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 5 syntheses or guidelines pooled it.
- Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.The Cochrane database of systematic reviews · 2022Pooled it
- Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.The Cochrane database of systematic reviews · 2022Pooled it
- Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.The Cochrane database of systematic reviews · 2021Pooled it
- Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.The Cochrane database of systematic reviews · 2021Pooled it
- Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data.Frontiers in medicine · 2021Pooled it
- Neurological complications caused by SARS-CoV-2.Clinical microbiology reviews · 2024Review
- Review
- Are Multiple Chemosensory Systems Accountable for COVID-19 Outcome?Journal of clinical medicine · 2021Review
- From loss to recovery: how to effectively assess chemosensory impairments during COVID-19 pandemic.medRxiv : the preprint server for health sciences · 2021Article
- Article
Corrections and comments
- Comment on
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
32978178What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.